News

Researchers have developed a new technique for fluorescence lifetime imaging of tissue and cells, which could lay the groundwork for use in a clinical setting.

Researchers at Cincinnati Children’s report in Science Translational Medicine that they have developed and successfully tested a new rapid blood assay that measures five biomarkers and accurately predicts which patients are at low, medium or high risk for death from sepsis.

Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications.

Case Western Reserve University researchers see a new opportunity in the CRISPR technique: a novel "universal biosensing" point-of-care medical device that rapidly and accurately detects troublesome viruses like human papillomavirus (HPV) or parvovirus (parvo).

A novel AI-driven solution is able to identify diagnostic blast cells at least as well as a trained cytologist expert, and could support physicians in leukemia diagnostics.

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

Without occasionally looking under the hood, it’s difficult to predict whether expensive car repairs lie ahead. In a similar way, preventive cardiologists are looking for ways to detect early stage heart disease in people who aren’t currently in treatment.

Researchers have discovered how nanoparticles could be used to develop a biosensor to prevent deadly diseases contracted on medical equipment.

A diagnostic study of 136 premature infants found that a protein involved in managing harmful bacteria in the human intestine is a reliable biomarker for the noninvasive detection of necrotizing enterocolitis (NEC).

Investigators have found that sesame allergy is common among children with other food allergies, occurring in an estimated 17% of this population.